CompletedNCT00656487
Rimonabant for cannabis withdrawal and thinking skills
About this title
Read the official source — NCT00656487Medication studyAges 21–30United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 21 years to 30 years.
- Listed locations
- La JollaSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: April 30, 2008
- Recruitment status
- Completed
- Enrollment listed in the registry
- 66
- Sponsor
- The Scripps Research Institute
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 21 Years to 30 Years
- Official registry ID
- NCT00656487
- Official title
Show the full official title
Translational Center on the Clinical Neurobiology of Cannabis Addiction
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
La Jolla
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is The Scripps Research Institute, a research institute.
Did this study involve medication?
Yes. The study involved medication, including rimonabant and placebo.
Who was this study for?
Listed age limits: 21 years to 30 years.
